Skip to main content
. 2016 Nov 7;6:36442. doi: 10.1038/srep36442

Figure 4. Seroreactivity for AlpA, OipA, BabA, and SabA in normal subjects and patients with gastritis, DU, or GC.

Figure 4

Purified recombinant AlpA, OipA, BabA, and SabA were probed with clinical serum samples by Western blotting and the relative immunoreactivity was measured and analyzed. The subjects were healthy individuals without H. pylori infection (n = 10), gastritis patients without H. pylori infection [GS (−), n = 5], gastritis patients with H. pylori infection [GS (+), n = 5], duodenal ulcer patients with H. pylori infection [DU (+), n = 80], and gastric cancer patients with H. pylori infection [GC (+), n = 76]. The horizontal red lines indicate the mean values for each group and the black dotted line indicates the cut-off value for seropositivity defined as the mean ± 2SD of the non-GC samples. *p < 0.05.